#Moderna
-
Moderna says RSV vaccine 84% effective at preventing symptoms in older adults
-
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
-
U.S. FDA authorizes Moderna, Pfizer-BioNTech COVID-19 vaccines for kids down to 6 months of age
-
Moderna COVID-19 vaccine may pose higher heart inflammation risk: US CDC
-
Moderna sees higher COVID vaccine sales in second half of 2022
-
Moderna asks Canada for extension of COVID vaccine to young children
-
Moderna recalls thousands of COVID vaccine doses in Europe
-
Uzbekistan receives 2,108,400 doses of Moderna vaccine as part of the COVAX program
-
Moderna to seek regulatory approval for COVID shot for very young children
-
Moderna plots vaccines against 15 pathogens with future pandemic potential
-
U.S. CDC recommends Moderna COVID-19 vaccine after FDA's full approval
-
U.S. FDA grants full approval to Moderna's COVID-19 vaccine
-
Moderna starts trial for Omicron-specific booster shot
-
Pfizer, Moderna boosters up to 90% effective against Omicron: CDC
-
4th Pfizer, Moderna shot less effective against Omicron: Israeli study
-
Moderna improves forecast for 2022 sales from COVID-19 vaccine
-
Moderna COVID-19 shot more likely to cause heart inflammation than Pfizer's
-
U.S. study suggests COVID-19 vaccines may be ineffective against Omicron without booster
-
Moderna's mRNA-based flu vaccine shows promise in early-stage study
-
Moderna exec says company could have Omicron booster ready in March
-
Oxford University says no evidence yet that vaccines won't protect against severe disease from Omicron
-
US company Moderna begins work on vaccine against new SARS-CoV-2 variant ‘Omicron’
-
Moderna seeks EU authorization for COVID-19 vaccine in young children
-
Moderna COVID shot could be used in U.S. children, teens within weeks
